The Need for Pediatric Formulations to Treat Children with HIV
about
Pediatric Human Immunodeficiency Virus Continuum of Care: A Concise Review of Evidence-Based Practice.Challenges and Opportunities in the Development of HIV Medications in Pediatric Patients.Neglected Population, Neglected Right: Children Living with HIV and the Right to Science.High Levels of Dual-Class Drug Resistance in HIV-Infected Children Failing First-Line Antiretroviral Therapy in Southern Ethiopia.Barriers and facilitators to antiretroviral therapy adherence among Peruvian adolescents living with HIV: A qualitative study.Use of Adult Sensory Panel to Study Individual Differences in the Palatability of a Pediatric HIV Treatment Drug.Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study.Modification of Initial Highly Active Antiretroviral Therapy (HAART) Regimen in Paediatric HIV Patients.The Palatability of Lopinavir and Ritonavir Delivered by an Innovative Freeze-Dried Fast-Dissolving Tablet Formulation.Making Implementation Science Work for Children and Adolescents Living With HIVLow Case Finding Among Men and Poor Viral Load Suppression Among Adolescents Are Impeding Namibia's Ability to Achieve UNAIDS 90-90-90 TargetsHope for the Future But Fear the Risk of Stigma: Ethiopian Family Caregivers’ Lived Experience of Caring for Their HIV Positive Child Two Years After Starting Antiretroviral Treatment
P2860
Q34682648-901C5D14-0A36-4753-8ED4-8203D5C3CFA3Q40377157-A9C86BA6-5624-4575-A07A-E3050ED46DD4Q47097059-30FB6979-3880-4354-8205-2F6F76E01F2CQ47547186-FA943C2B-AD26-4B96-A832-1505EFCC261FQ49979924-67369D31-46B5-4964-BA17-904091E7834AQ50040651-918FA335-7403-47F7-9822-BF5B42543E0EQ53283586-F2A1315E-BFCA-4531-A291-F462584C69F9Q53835112-0EB886F8-DF61-41CD-9583-B11056633B82Q55215843-C55BB7E4-CC4E-432C-939F-77FC835D120FQ56910410-4FFB6EDB-A7EB-426D-BFBE-36519141BE21Q58788224-63FED837-9A87-44CD-9EC4-6C7D3599D55FQ58838196-BA351AD3-793E-4487-9EF2-F3BF3DC24B37
P2860
The Need for Pediatric Formulations to Treat Children with HIV
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The Need for Pediatric Formulations to Treat Children with HIV
@ast
The Need for Pediatric Formulations to Treat Children with HIV
@en
The Need for Pediatric Formulations to Treat Children with HIV
@nl
type
label
The Need for Pediatric Formulations to Treat Children with HIV
@ast
The Need for Pediatric Formulations to Treat Children with HIV
@en
The Need for Pediatric Formulations to Treat Children with HIV
@nl
prefLabel
The Need for Pediatric Formulations to Treat Children with HIV
@ast
The Need for Pediatric Formulations to Treat Children with HIV
@en
The Need for Pediatric Formulations to Treat Children with HIV
@nl
P2093
P2860
P50
P3181
P356
P1476
The Need for Pediatric Formulations to Treat Children with HIV
@en
P2093
Adrienne F Schlatter
Andrew R Deathe
Rachel C Vreeman
P2860
P304
P3181
P356
10.1155/2016/1654938
P407
P577
2016-06-16T00:00:00Z